343 related articles for article (PubMed ID: 9316857)
41. Down-regulation of rat hepatic microsomal cytochromes P-450 in microvesicular steatosis induced by orotic acid.
Su GM; Sefton RM; Murray M
J Pharmacol Exp Ther; 1999 Dec; 291(3):953-9. PubMed ID: 10565810
[TBL] [Abstract][Full Text] [Related]
42. Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae.
Brian WR; Sari MA; Iwasaki M; Shimada T; Kaminsky LS; Guengerich FP
Biochemistry; 1990 Dec; 29(51):11280-92. PubMed ID: 2271712
[TBL] [Abstract][Full Text] [Related]
43. Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats.
Suzuki T; Narimatsu S; Fujita S; Masubuchi Y; Umeda S; Imaoka S; Funae Y
Drug Metab Dispos; 1992; 20(3):367-73. PubMed ID: 1355709
[TBL] [Abstract][Full Text] [Related]
44. Monoclonal antibodies inhibitory to rat hepatic cytochromes P-450: P-450 form specificities and use as probes for cytochrome P-450-dependent steroid hydroxylations.
Waxman DJ; Lapenson DP; Park SS; Attisano C; Gelboin HV
Mol Pharmacol; 1987 Nov; 32(5):615-24. PubMed ID: 3119986
[TBL] [Abstract][Full Text] [Related]
45. Expression of a rat liver microsomal cytochrome P-450 catalyzing testosterone 16 alpha-hydroxylation in Saccharomyces cerevisiae: vitamin D3 25-hydroxylase and testosterone 16 alpha-hydroxylase are distinct forms of cytochrome P-450.
Hayashi S; Morohashi K; Yoshioka H; Okuda K; Omura T
J Biochem; 1988 May; 103(5):858-62. PubMed ID: 3053677
[TBL] [Abstract][Full Text] [Related]
46. Pyrazole is different from acetone and ethanol as an inducer of the polysubstrate monooxygenase system in mice: evidence that pyrazole-inducible P450Coh is distinct from acetone-inducible P450ac.
Honkakoski P; Autio S; Juvonen R; Raunio H; Gelboin HV; Park SS; Pelkonen O; Lang MA
Arch Biochem Biophys; 1988 Dec; 267(2):589-98. PubMed ID: 3214171
[TBL] [Abstract][Full Text] [Related]
47. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
[TBL] [Abstract][Full Text] [Related]
48. Immunochemical detection of cytochrome P450 enzymes in liver microsomes of 27 cynomolgus monkeys.
Uehara S; Murayama N; Nakanishi Y; Zeldin DC; Yamazaki H; Uno Y
J Pharmacol Exp Ther; 2011 Nov; 339(2):654-61. PubMed ID: 21849623
[TBL] [Abstract][Full Text] [Related]
49. Purification and characterization of a form of P450 from horse liver microsomes.
Komori M; Higami A; Imai Y; Imaoka S; Funae Y
J Biochem; 1993 Sep; 114(3):445-8. PubMed ID: 8282739
[TBL] [Abstract][Full Text] [Related]
50. Debrisoquine 4-hydroxylase: characterization of a new P450 gene subfamily, regulation, chromosomal mapping, and molecular analysis of the DA rat polymorphism.
Gonzalez FJ; Matsunaga T; Nagata K; Meyer UA; Nebert DW; Pastewka J; Kozak CA; Gillette J; Gelboin HV; Hardwick JP
DNA; 1987 Apr; 6(2):149-61. PubMed ID: 3582092
[TBL] [Abstract][Full Text] [Related]
51. Impairment of debrisoquine 4-hydroxylase and related monooxygenase activities in the rat following treatment with propranolol.
Masubuchi Y; Fujita S; Chiba M; Kagimoto N; Umeda S; Suzuki T
Biochem Pharmacol; 1991 Mar 15-Apr 1; 41(6-7):861-5. PubMed ID: 2009081
[TBL] [Abstract][Full Text] [Related]
52. An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: relevance to its use as a model of the CYP2D6 poor metaboliser phenotype.
Barham HM; Lennard MS; Tucker GT
Biochem Pharmacol; 1994 Apr; 47(8):1295-307. PubMed ID: 8185638
[TBL] [Abstract][Full Text] [Related]
53. Rat cytochrome P450 2C11 in liver microsomes involved in oxidation of anesthetic agent propofol and deactivated by prior treatment with propofol.
Yamazaki H; Shimizu M; Nagashima T; Minoshima M; Murayama N
Drug Metab Dispos; 2006 Nov; 34(11):1803-5. PubMed ID: 16896062
[TBL] [Abstract][Full Text] [Related]
54. Progesterone oxidation by cytochrome P450 2D isoforms in the brain.
Hiroi T; Kishimoto W; Chow T; Imaoka S; Igarashi T; Funae Y
Endocrinology; 2001 Sep; 142(9):3901-8. PubMed ID: 11517168
[TBL] [Abstract][Full Text] [Related]
55. Interspecies homology of cytochrome P-450: inhibition by anti-P-450-male antibodies of testosterone hydroxylases in liver microsomes from various animal species including man.
Miura T; Shimada H; Ohi H; Komori M; Kodama T; Kamataki T
Jpn J Pharmacol; 1989 Mar; 49(3):365-74. PubMed ID: 2747039
[TBL] [Abstract][Full Text] [Related]
56. Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin.
Eberhart DC; Gemzik B; Halvorson MR; Parkinson A
Mol Pharmacol; 1991 Nov; 40(5):859-67. PubMed ID: 1944247
[TBL] [Abstract][Full Text] [Related]
57. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A
Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963
[TBL] [Abstract][Full Text] [Related]
58. Inhibitory effects of curcumin on activity of cytochrome P450 2C9 enzyme in human and 2C11 in rat liver microsomes.
Wang Z; Sun W; Huang CK; Wang L; Xia MM; Cui X; Hu GX; Wang ZS
Drug Dev Ind Pharm; 2015 Apr; 41(4):613-6. PubMed ID: 24517573
[TBL] [Abstract][Full Text] [Related]
59. Immunochemical evidence for the catalysis of vitamin D3 25-hydroxylation and testosterone 16 alpha-hydroxylation by homologous forms of cytochrome P-450 in rat liver microsomes.
Hayashi S; Omura T; Watanabe T; Okuda K
J Biochem; 1988 May; 103(5):853-7. PubMed ID: 2460437
[TBL] [Abstract][Full Text] [Related]
60. (+)-bufuralol 1'-hydroxylation activity in human and rhesus monkey intestine and liver.
Prueksaritanont T; Dwyer LM; Cribb AE
Biochem Pharmacol; 1995 Oct; 50(9):1521-5. PubMed ID: 7503805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
